MG29-1

MG29-1 is a research-stage compound identified as a small molecule modulator of Mitsugumin 29 (MG29), a protein essential for the structural integrity and function of the triad junction in skeletal muscle. MG29 is a member of the synaptophysin family and plays a critical role in excitation-contraction coupling and calcium signaling within muscle fibers. MG29-1 is primarily investigated for its potential to mitigate muscle atrophy and dysfunction associated with aging (sarcopenia), muscular dystrophy, and other muscle-wasting conditions. By targeting MG29, the compound aims to stabilize the sarcoplasmic reticulum and improve calcium handling, thereby preserving muscle mass and contractile performance. Development is largely centered in academic and early-stage biotech research environments focusing on musculoskeletal disorders.